Galectin-9 ameliorates immune complex-induced arthritis by regulating FcγR expression on macrophages

Clinical Immunology

Volumn 133, Issue 3, 2009, Pages 382-392

  Arikawa, Tomohiro ^a   Watanabe, Kota ^a   Seki, Masako ^a   Matsukawa, Akihiro ^b   Oomizu, Souichi ^a   Sakata, Ken mei ^c   Sakata, Atsuko ^d   Ueno, Masaki ^e   Saita, Naoki ^f   Niki, Toshiro ^e   Yamauchi, Akira ^e   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Nishigohshi Hospital   (Japan)

^d Kumamoto University   (Japan)

^e KAGAWA UNIVERSITY   (Japan)

^f KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Arthritis; Fc RIIb; Fc RIII; Galectin 9; Immune complex; Macrophage

Indexed keywords

COMPLEMENT COMPONENT C5A; ECALECTIN; FC RECEPTOR; FC RECEPTOR IIB; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; IN VITRO STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; FLOW CYTOMETRY; GALECTINS; HISTOCYTOCHEMISTRY; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC;

EID: 70350576601     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.09.004     Document Type: Article

References (35)

1. Combe B. Progression in early rheumatoid arthritis. Best. Pract. Res. Clin. Rheumatol. 23 (2009) 59-69
2. Dhaouadi T., Sfar I., Abelmoula L., Jendoubi-Ayed S., Aouadi H., Ben Abdellah T., Ayed K., Zouari R., and Gorgi Y. Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review. Tunis. Med. 85 (2007) 991-998
3. Syversen S.W., Goll G.L., van der Heijde D., Landewé R., Gaarder P.I., Odegård S., Haavardsholm E.A., and Kvien T.K. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J. Rheumatol. 36 (2009) 266-272
4. Kuper H.H., van Leeuwen M.A., van Riel P.L., Prevoo M.L., Houtman P.M., Lolkema W.F., and van Rijswijk M.H. Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability. Br. J. Rheumatol. 36 (1997) 855-860
5. Smolen J.S., Aletaha D., and Steiner G. Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann. Rheum. Dis. 68 (2009) 159-162
6. Rabinovich G.A., Liu F.T., Hirashia M., and Anderson A. An emerging role for galectins in tuning the immune responses: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand. J. Immunol. 66 (2007) 143-158
7. Seki M., Sakata K.M., Oomizu S., Arikawa T., Sakata A., Ueno M., Nobumoto A., Niki T., Saita N., Ito K., Dai S.Y., Katoh S., Nishi N., Tsukano M., Ishikawa K., Yamauchi A., Kuchroo V., and Hirashima M. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 56 (2007) 3968-3976
8. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V., and Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127 (2008) 78-88
9. Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Kontani K., Kihara M., Zhang S.L., Hata T., Nakamura T., Yamauchi A., and Hirashima M. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 175 (2005) 2974-2981
10. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., Bruce J.N., Kane L.P., Kuchroo V.K., and Hafler D.A. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318 (2007) 1141-1143
11. Thorvaldson L., Fuchs D., Magnusson S., and Kleinau S. IgG immune complex-binding in macrophages from arthritis-susceptible and arthritis-resistant mice following collagen type II immunization. Scand. J. Immunol. 63 (2006) 347-354
12. Nandakumar K.S., and Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CIAI) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J. Immunol. Methods 304 (2005) 126-136
13. Blom A.B., Radstake T.R., Holthuysen A.E., Slöetjes A.W., Pesman G.J., Sweep F.G., van de Loo F.A., Joosten L.A., Barrera P., van Lent P.L., and van den Berg W.B. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum. 48 (2003) 1002-1014
14. Boross P., van Lent P.L., Martin-Ramirez J., van der Kaa J., Mulder M.H., Claassens J.W., van den Berg W.B., Arandhara V.L., and Verbeek J.S. Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII. J. Immunol. 180 (2008) 5083-5091
15. Blom A.B., Radstake T.R., Holthuysen A.E., Sloetjes A.W., Pesman G.J., Sweep F.G., van de Loo F.A., Joosten L.A., Barrera P., van Lent P.L., and van den Berg W.B. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum. 48 (2003) 1002-1014
16. Broker B.M., Edwards J.C., Fanger M.W., and Lydyard P.M. The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. Scand. J. Rheumatol. 19 (1990) 123-135
17. Skokowa J., Ali S.R., Felda O., Kumar V., Konrad S., Shushakova N., Schmidt R.E., Piekorz R.P., Nürnberg B., Spicher K., Birnbaumer L., Zwirner J., Claassens J.W., Verbeek J.S., van Rooijen N., Köhl J., and Gessner J.E. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J. Immunol. 174 (2005) 3041-3050
18. Edwards J.C., Blades S., and Cambridge G. Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA). Clin. Exp. Immunol. 108 (1997) 401-406
19. Ji H., Ohmura K., Mahmood U., Lee D.M., Hofhuis F.M., Boackle S.A., Takahashi K., Holers V.M., Walport M., Gerard C., Ezekowitz A., Carroll M.C., Brenner M., Weissleder R., Verbeek J.S., Duchatelle V., Degott C., Benoist C., and Mathis D. Arthritis critically dependent on innate immune system players. Immunity 16 (2002) 157-168
20. Tsuboi Y., Abe H., Nakagawa R., Oomizu S., Watanabe K., Nishi N., Nakamura T., Yamauchi A., and Hirashima M. Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin. Immunol. 124 (2007) 221-233
21. Nishi N., Itoh A., Fujiyama A., Yoshida N., Araya S., Hirashima M., Shoji H., and Nakamura T. Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett. 579 (2005) 2058-2064
22. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., Stevens R.L., and Hirashima M. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273 (1998) 16976-16984
23. Brand D.D., Kang A.H., and Rosloniec E.F. The mouse model of collagen-induced arthritis. Methods Mol. Med. 102 (2004) 295-312
24. K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, JA. Van Ginderachter, Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, 111 (2008) 4233-44.
25. Villalta S.A., Nguyen H.X., Deng B., Gotoh T., and Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18 (2009) 482-496
26. Albright C.A., Sartor R.B., and Tonkonogy S.L. Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria. Immunol. Lett. 123 (2009) 77-87
27. Arikawa T., Matsukawa A., Watanabe K., Sakata K.M., Seki M., Nagayama M., Takeshita K., Ito K., Niki T., Oomizu S., Shinonaga R., Saita N., and Hirashima M. Galectin-9 accelerates transforming growth factor beta3-induced differentiation of human mesenchymal stem cells to chondrocytes. Bone 44 (2009) 849-857
28. Clynes R., Maizes J.S., Guinamard R., Ono M., Takai T., and Ravetch J.V. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189 (1999) 179-185
29. Monsinjon T., Gasque P., Ischenko A., and Fontaine M. C3a binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8. FEBS Lett. 487 (2001) 339-346
30. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., and Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157 (1996) 1693-1698
31. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66 (2006) 1123-1131
32. Youn J.I., Nagaraj S., Collazo M., and Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181 (2008) 5791-5802
33. Kawamura K., Komohara Y., Takaishi K., Katabuchi H., and Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol. Int. 59 (2009) 300-305
34. Shabo I., Stål O., Olsson H., Doré S., and Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int. J. Cancer 123 (2008) 780-786
35. Martens J.H., Kzhyshkowska J., Falkowski-Hansen M., Schledzewski K., Gratchev A., Mansmann U., Schmuttermaier C., Dippel E., Koenen W., Riedel F., Sankala M., Tryggvason K., Kobzik L., Moldenhauer G., Arnold B., and Goerdt S. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J. Pathol. 208 (2006) 574-589